E
IART icon

Ergoteles’s Integra LifeSciences IART Stock Holding History

Ergoteles’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,525
Closed -$597K – 414
2023
Q2 		$597K Buy
+14,525
New +$699K 0.03% 598
2022
Q4 		– Sell
-41,951
Closed -$1.78M – 1651
2022
Q3 		$1.78M Buy
41,951
+33,228
+381% +$1.7M 0.06% 309
2022
Q2 		$471K Buy
+8,723
New +$524K 0.01% 860
2021
Q2 		– Sell
-22,494
Closed -$1.55M – 1578
2021
Q1 		$1.55M Buy
+22,494
New +$1.52M 0.05% 315

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ergoteles's IART Position: Q3 2023 in Review

Ergoteles sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 14,525 shares — an estimated $597K sold.

Ergoteles first reported a position in IART in Q1 2021 and held it in 4 quarters. The position peaked at $1.78M in Q3 2022. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Ergoteles reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 14,525 Integra LifeSciences shares in Q3 2023, an estimated $597K.
  • Ergoteles first reported a position in Integra LifeSciences in Q1 2021 and held it in 4 quarters.
  • Ergoteles's Integra LifeSciences position peaked at $1.78M in Q3 2022.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.